NEW YORK (GenomeWeb) – Columbia University Medical Center and New York-Presbyterian announced a $58.4 million grant from the National Institutes of Health and its National Center for Advancing Translational Sciences (NCATS).
With the five-year grant, the Irving Institute for Clinical and Translational Research will invest further in personalized medicine. It will provide resources for training and research in personalized medicine and develop translational therapeutics.
The Irving Institute is a partnership between CUMC and New York-Presbyterian healthcare system. Since 2006, it has received more than $150 million in funding from the NCATS Clinical and Translational Science Award program.
"This award will launch new programs that complement the Precision Medicine Initiative of Columbia University and New York-Presbyterian while continuing our important work in areas of training, multidisciplinary team science, data science infrastructure innovation and development, and community engagement in clinical and translational research," Irving Institute Director Designate Muredach Reilly said in a statement.